Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Tumori
|
January 31, 1998
[Low-dose GM-CSF and dose intensity of antineoplastic agents]
P Pronzato, F Pensa, F Vaira, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 1998
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study
P Pronzato, P Losardo, F Pensa, et al.
British Journal of Cancer
|
September 22, 1998
High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study
P Pronzato, R Lionetto, F Botto, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 28, 1998
A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer
P Pronzato, A Tognoni, F Pensa, et al.
American Journal of Clinical Oncology
|
November 5, 1997
Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer
P Pronzato, A Vigani, F Pensa, et al.
The Prostate
|
January 1, 1994
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion
A Decensi, R Torrisi, P Marroni, et al.
Anticancer Research
|
March 28, 2001
Sequential high dose-density chemotherapy in advanced ovarian cancer
A Tognoni, P Pronzato, L Cadenotti, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 18, 2002
A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer
A Tognoni, F Pensa, F Vaira, et al.
International Journal of Cancer
|
December 15, 1994
Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content
S Zanardi, F Pensa, R Torrisi, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 21, 1998
A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer
P Pronzato, F Botto, E Ghio, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Tumori
|
January 31, 1998
[Low-dose GM-CSF and dose intensity of antineoplastic agents]
P Pronzato, F Pensa, F Vaira, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 1998
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study
P Pronzato, P Losardo, F Pensa, et al.
British Journal of Cancer
|
September 22, 1998
High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study
P Pronzato, R Lionetto, F Botto, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 28, 1998
A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer
P Pronzato, A Tognoni, F Pensa, et al.
American Journal of Clinical Oncology
|
November 5, 1997
Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer
P Pronzato, A Vigani, F Pensa, et al.
The Prostate
|
January 1, 1994
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion
A Decensi, R Torrisi, P Marroni, et al.
Anticancer Research
|
March 28, 2001
Sequential high dose-density chemotherapy in advanced ovarian cancer
A Tognoni, P Pronzato, L Cadenotti, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 18, 2002
A dose finding study of carboplatin and gemcitabine in advanced non-small cell lung cancer
A Tognoni, F Pensa, F Vaira, et al.
International Journal of Cancer
|
December 15, 1994
Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content
S Zanardi, F Pensa, R Torrisi, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 21, 1998
A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer
P Pronzato, F Botto, E Ghio, et al.
Page
of 3